Detalhe da pesquisa
1.
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Br J Haematol
; 184(2): 215-222, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30183069
2.
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.
Br J Haematol
; 180(1): 60-70, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164606
3.
E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors.
Oncologist
; 23(9): 1006-e104, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853660
4.
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
Br J Haematol
; 176(3): 412-420, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27982425
5.
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia.
Blood
; 125(15): 2336-43, 2015 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25696919
6.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem
; 3(2): 394-405, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846031
7.
Primary Gastric Choriocarcinoma: A Case Report of Early Successful Treatment Outcome.
JCO Oncol Pract
; 16(9): 608-610, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32364827
8.
Acute myeloid leukemia with t(4;12)(q12;p13) treated with an allogeneic stem cell transplant: A case report and review of the literature.
Leuk Res Rep
; 9: 76-78, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892553
9.
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy.
J Clin Oncol
; 29(3): 287-93, 2011 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135284
10.
High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma.
Biol Blood Marrow Transplant
; 9(6): 383-8, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12813446